Atlas Trials

Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection

Clinical trial NCT04362865 · COMPLETED

Trial details

NCT number
NCT04362865
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19
Start date
2020-04-27
Primary completion
2025-02-10
Enrollment
679

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.